Novo Holdings vend 327 919 actions Lexeo, conserve 148,13 M$ en Edgewise et 3,52 M$ en IO Biotech. Novo Holdings sells 327,919 Lexeo shares, retains $148.13m in Edgewise and $3.52m in IO Biotech.

Novo Holdings A S a récemment vendu 327 919 actions de Lexeo Therapeutics, Inc. (NASDAQ:LXEO). Novo Holdings A S has recently sold 327,919 shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO). De plus, la société détient 148,13 millions de dollars dans Edgewise Therapeutics, Inc. (NASDAQ:EWTX) et détient 3,52 millions de dollars dans IO Biotech, Inc. (NASDAQ:IOBT). Additionally, the firm holds $148.13 million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) and has a $3.52 million position in IO Biotech, Inc. (NASDAQ:IOBT).